U.S. stocks closed rallied on Friday, with the Nasdaq Composite (COMP:IND) securing another back-to-back record, even as ...

President Donald Trump is weighing whether to reclassify cannabis as a less dangerous drug. People familiar with the matter ...

An official overseeing implementation of the Make America Healthy Again agenda at the Department of Health and Human Services ...

Tesla’s board is giving Chief Executive Elon Musk a $23.7 billion stock award —so long as he stays focused on the company.

Last week, President Trump sent letters to 17 major pharmaceutical companies advising them to work with his administration to ...

The FTSE 100 edged down on Friday on a mixed day for European equities despite new optimism about an end to the war between ...

CSL Seqirus was one of the drugmakers the federal government listed this week as having its mRNA-related work cut. In an ...

The U.S. government has been discussing with drugmakers how to raise overseas drug prices as President Donald Trump seeks to implement his Most Favored Nation policy, which attempts to lower U.S. drug ...

SERB Pharmaceuticals plans to buy Y-mAbs Pharmaceuticals in a $412 million all-cash deal. CorMedix bought Melinta ...

US Health Secretary Robert F. Kennedy Jr. has slashed government spending on mRNA vaccine research. Experts warn it will ...

The president who ran on his business acumen isn’t holding back in telling corporate bosses how to run their companies—or ...

American shoppers hit with 60% of costs as import taxes reach 100-year high - Tariffs on U.S. trading partners finally in full effect months after ‘Liberation Day’ announcement and ensuing turmoil and ...